Wendy Putnam is the Vice President of Clinical Pharmacology & DMPK at Ultragenyx, specializing in drug development for rare diseases. Her expertise covers biotherapeutics and small molecules. She holds a PhD from the University of California, San Francisco and a BS from The Johns Hopkins University.
Her posts frequently highlight opportunities to join her team, emphasizing a collaborative and impactful work environment. She appears passionate about recruiting top talent to help advance therapies for patients with rare diseases.
Wendy previously served as the Pharmacology Team Leader for the asthma drug Lebrikizumab while at Genentech.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.